NetworkNewsBreaks – Innovus Pharma (INNV) Receives Receipt of Notification to Commercialize Zestra® in the EU; Shares Rise

Innovus Pharmaceuticals (OTCQB: INNV) shares are higher this morning after the company said that it received the CPNP notification number required to commercialize Zestra® in all 28 member countries of the European Union. The over-the-counter consumer goods and specialty pharmaceutical company is engaged in commercialization, licensing and development of safe and effective non-prescription medicine. In addition to the largest market for Zestra®, the United States, Innovus Pharma currently generates Zestra® revenues from markets in Canada, Morocco, certain European countries and Hong Kong. “We are pleased to expand the commercialization market for Zestra® to the second largest market in the world and believe this will enhance our partnering discussions in EU member countries and eventually expand our sales into this region,” Innovus Pharma CEO Dr. Bassam Damaj stated in the news release.

To view the full press release, visit:

About Innovus Pharmaceuticals, Inc.

Headquartered in San Diego, Innovus Pharma is an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases. Innovus Pharma delivers innovative and uniquely presented and packaged health solutions through its (a) OTC medicines and consumer and health products, which we market directly, (b) commercial partners to primary care physicians, urologists, gynecologists and therapists, and (c) directly to consumers through our on-line channels, retailers and wholesalers. The company is dedicated to being a leader in developing and marketing new OTC and branded Abbreviated New Drug Application products. The company is actively pursuing opportunities where existing prescription drugs have recently, or are expected to, change from prescription (or Rx) to OTC. For more information, visit

About NetworkNewsBreak

NetworkNewsBreak (NNB) provides a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, visit

Please see full disclaimers on the NetworkNewsWire website:

NetworkNewsWire (NNW)
New York, New York
212.418.1217 Office

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s